Equine arteritis viruses (EAV) from Europe and America were compared by phylogenetic analysis of 43 isolates obtained over four decades. An additional 22 virus sequences were retrieved from GenBank. Fragments of the glycoprotein G L and the replicase genes were amplified by RT-PCR, prior to sequencing and construction of phylogenetic trees. The trees revealed many distinctive lineages, consistent with prolonged diversification within geographically separated host populations. Two large groups and five subgroups were distinguished. Group I consisted mainly of viruses from North America, whilst group II consisted mainly of European isolates. In most instances, where the geographic origin of the viruses appeared to be at variance with the phylogenetically predicted relationships, the horses from which the viruses were recovered had been transported between Europe and America or vice versa. Analysis of the replicase gene revealed similar phylogenetic relationships although not all of the groups were as clearly defined. Virus strains CH1 (Switzerland, 1964) and S1 (Sweden, 1989) represented separate ' outgroups ' based on analysis of both genomic regions. The results of this study confirm the value of the G L gene of EAV for estimating virus genetic diversity and as a useful tool for tracing routes by which EAV is spread. In addition, computer-assisted predictions of antigenic sites on the G L protein revealed considerable variability among the isolates, especially with respect to regions associated with neutralization domains. 0001-5799 # 1999 Crown Copyright GJB
Introduction
Equine arteritis virus (EAV) is a member of the family Arteriviridae, along with porcine reproductive and respiratory syndrome virus, simian haemorrhagic fever virus and lactate dehydrogenase-elevating virus. The families Arteriviridae and Author for correspondence : S. Bela! k. Coronaviridae constitute the order Nidovirales (Cavanagh, 1997) .
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USA changes in viral RNA have been observed in a stallion by Murphy et al. (1992) . The EAV genome consists of a single positive-stranded RNA, polyadenylated at the 3h end, and contains eight open reading frames (ORFs 1a and 1b, 2-7) (de Vries et al., 1997 ; Snijder & Meulenberg, 1998) . ORFs 1a and 1b encode the viral replicase. The ORF 1a protein is processed by virus-encoded proteases into six major end-products, non-structural proteins 1-6 (nsp1-nsp6) (Snijder et al., 1994) . The ORF 1b protein is processed by an nsp4 serine protease into 80, 50, 25 and 12 kDa proteins (van Dinten et al., 1996) . ORFs 2, 5 and 6 encode the viral membrane proteins and ORF 7 encodes the nucleocapsid protein. The 25 kDa (G S ) and 29 kDa (G L ) envelope proteins are encoded by ORFs 2 and 5, respectively, whereas ORF 6 encodes a 17 kDa unglycosylated envelope protein. The G L envelope glycoprotein, encoded by ORF 5, expresses neutralization determinants of EAV (Balasuriya et al., 1993 Chirnside et al., 1995 ; Glaser et al., 1995) .
Although EAV occurs in horse populations in many countries, relatively little information is available on the genetic variability among isolates of the virus from different regions of the world (Murphy et al., 1988 (Murphy et al., , 1992 . Phylogenetic analysis of M and N protein genes of ten EAV isolates confirmed strain variation, and it has been suggested that RNA recombination may have occurred between these viruses (Chirnside et al., 1994) . Sugita et al. (1994) separated distinct geographic groups of EAV isolates from Europe and the USA, based on sequence analysis of the M protein gene. A subsequent study by in which a phylogenetic tree was constructed based on ORF 5 sequences of 22 strains of EAV from North America and Europe, revealed four distinct groups among the EAV isolates investigated (two North American and two European groups). Analysis of genetic variation of the G S protein gene confirmed this observation (Lepage et al., 1996 ; Hedges et al., 1996) . Similar segregation of a more limited number of strains was obtained by analysis of the G L protein (St-Laurent et al., 1997) and ORFs 3 and 4 (Archambault et al., 1997) .
The goal of the present work was to study the genetic variability among a large collection of American and European isolates of EAV collected over a period of four decades. In view of the fact that ORF 5 was found to be a more useful target for phylogenetic analysis than ORF 2 Hedges et al., 1996) , the present work focused on a variable region of the G L gene. A second region, involving a fragment of the gene encoding the viral replicase subunits p26\p12 was also analysed.
Methods

Viruses.
A total of 43 isolates of EAV from Austria, Canada, France, Germany, Italy, the Netherlands, New Zealand, Norway, Poland, Sweden, Switzerland, the UK and the USA was studied ( Table 1) . The viruses were propagated in RK13 or VERO cells using established procedures (Timoney et al., 1986) . Alternatively, RT-PCR products were obtained directly from organ and semen specimens as described by Bela! k et al. (1994 Bela! k et al. ( , 1996 , with the modifications given below.
RNA extraction.
A 150 µl amount of each specimen was treated with 400 µl 6 M guanidine isothiocyanate at room temperature for 10 min. Subsequently, 225 µl 5 M NaCl and 200 µl chloroform were added. After vortexing for 10 s, the tube was placed on ice for 10 min, then centrifuged at 15 800 g for 10 min and 600 µl upper phase was transferred into a fresh Eppendorf tube. Total RNA was precipitated with 360 µl 95 % ethanol at k20 mC overnight and then pelleted at 15 800 g for 30 min. The pellet was washed twice with 70 % ethanol, dried and dissolved in 15 µl DEPC-treated water ; 5 µl purified total RNA was used in the reverse transcription reaction.
Reverse transcription. Prior to reverse transcription, 5 µl RNA solution was denatured in the presence of 0n02 U random hexamers (Pharmacia) for 5 min at 65 mC, under a mineral oil overlay, then cooled on ice. The reaction mixture was incubated at 37 mC for 90 min after the addition of 5 µl 5i first-strand buffer (Life Technologies), 2n5 µl each dNTP (2 mM) (Pharmacia), 24 U RNAguard (Pharmacia), and 200 U Moloney murine leukaemia virus reverse transcriptase (Life Technologies). The total volume of the reaction mixture was 28 µl. Following this reaction, the enzyme was inactivated by heating at 98 mC for 10 min.
Primers. Primers were selected using the Oligo 4.0 computer program (National Biosciences, Plymouth, MN, USA). Their locations within the genome of the Bucyrus strain of EAV (den Boon et al., 1991) were as follows : external G L pair, EAV31 (sense primer) 11253 5h GAC GGA TCG CGG CGT TAT TG 3h, OEVA18 (antisense primer) 5h GGT AGG AAC CCA ACT GAC GGT G 3h 12603, flanking a 1309 nt region ; nested G L pair, CR2 (sense primer) 11272 5h GCC A(A\G)T TTG CTG CGA TAT GAT GA 3h, EAV32 (antisense primer) 5h TGG GCC TAC CTG GGA CTA ACA AC 3h 11836, flanking a 519 nt fragment ; external replicase pair, EAV11 (sense primer) 9266 5h GTC TAT GCT CCA TCA TTT GAA CCT 3h, EAV12 (antisense primer) 5h GAA CCA ATT TGT AAG AAG TTG AAC AG 3h 9732, flanking a 417 nt region ; and nested replicase pair, EAV24 (sense primer) 9281 5h TTT GAA CCT TAT CTA CAC CCT GA 3h, EAV25 (antisense primer) 5h CTC TAG TGC ACA AAT GGT CTG 3h 9694, flanking a 370 nt region.
PCR amplification. Amplification was performed in a DNA Thermal Cycler (Perkin-Elmer), using Taq DNA polymerase (AmpliTaq ; Perkin-Elmer). The first amplification cycle of the G L fragment was performed in a 50 µl reaction volume. The reaction mixture comprised 5 µl 10i PCR buffer II (Perkin-Elmer) ; 5 % DMSO ; 2 mM MgCl # ; 250 µM dNTP (each) ; 25 pmol each primer (EAV31 and OEVA18) ; 2 U Taq DNA polymerase and 5 µl cDNA. Amplification involved 30 cycles of denaturation at 94 mC for 45 s, primer annealing at 53 mC for 1 min and primer extension at 72 mC for 1n5 min. The nested amplification cycle was performed in a 100 µl reaction volume. The reaction mixture comprised 10 µl 10i PCR buffer II (Perkin-Elmer) ; 2n5 mM MgCl # ; 250 µM dNTP (each) ; 50 pmol each primer (CR2 and EAV32) ; 2 U Taq DNA polymerase ; and 5 µl of the first PCR product. Amplification involved 40 cycles of denaturation at 94 mC for 45 s, primer annealing at 52 mC for 1 min and primer extension at 72 mC for 1n5 min.
The amplification cycle of the replicase fragment differed in the following respects. In the first round, the reaction mixture contained no DMSO, 1 mM MgCl # and 1 U Taq DNA polymerase, the annealing temperature was 48 mC and there were 40 cycles of amplification. In the nested PCR, the reaction mixture contained 1n5 mM MgCl # . The PCR products (5 µl samples) were run on 2 % agarose gels. The DNA bands were visualized under UV light after ethidium bromide staining.
Nucleotide sequencing and analysis. Prior to sequencing, the nested PCR products were purified and concentrated using the QIAquick PCR Purification kit (QIAGEN) in accordance with the manufacturer's recommendations. The products were cycle-sequenced using automated ABI PRISM Model 377 apparatus, based on incorporation of fluorescently labelled dideoxynucleotide terminators. Sequences of both strands of G L PCR products were determined using primers CR2 and EAV32. To determine the sequences in the replicase region of selected strains, PCR products were sequenced using primers EAV24 and EAV25. For nucleotide and amino acid sequence analysis the DNASTAR program (DNASTAR, Madison, WI, USA) was used. For phylogenetic analysis, the PHYLIP 3.5 phylogenetic inference program (Felsenstein, 1989 ) was used. The program DNADIST, involving Kimura's two-parameter distance concept, was used to establish a distance matrix from the sequence data. Based on the data derived from the DNADIST program, phylogenetic trees were constructed according to the Fitch-Margoliash method (FITCH). Bootstrap sampling was carried out on 100 replicate data sets to assess the confidence limits of the branch pattern. To predict potential antigenic determinants in the G L protein, the algorithm of Jameson-Wolf was applied (Jameson & Wolf, 1988) . It is comprised of subroutines to determine hydrophilicity, surface probabilities, backbone or chain flexibility, hydropathy and secondary structure.
Results and Discussion
Phylogenetic studies
A large panel of viruses was assembled for this study. Previous investigations have involved relatively small numbers of virus isolates, or the viruses examined have been limited in their geographic coverage, particularly with respect to Europe. To avoid possible confusion caused by the different names used by various authors for strain identification, we have used the nomenclature presented in Table 1 . An international agreement on a systematic and informative method for naming EAV isolates would be highly desirable.
Using nested RT-PCR, the predicted sizes of fragments of the G L and replicase genes were amplified from the genomes of each virus studied (G L , 565 nt ; replicase, 414 nt) and visualized in ethidium bromide-stained agarose gels (not shown). Nucleotide sequences of all of the G L and of selected replicase PCR products were determined and compared with one another. The G L sequences were also compared with 22 sequences obtained from GenBank. In the G L fragment, F2 and USA21 were the two most diverse isolates which showed nucleotide identities of 75n7 %, while in the replicase fragment, F1 and N1 showed the lowest identity of 80n5%.
Phylogenetic trees depicting the relationship of the viruses to each other are provided in Figs 1 and 2. Both show a radial structure with long branches and many distinctive isolates suggesting that either EAV evolves very quickly, or else that the isolates do not share a recent common ancestor. The former theory seems unlikely, since old isolates are sometimes similar to new ones, and since some geographically and temporally distant isolates are in fact closely related. Thus, it is more likely that the observed grouping represents the evolution of different lineages over a long time period, and the lack of recent branching is probably due to the relatively small sample size from within each geographic location. This would imply the existence of independent pockets of infection which have been able to survive for many years in localized equine populations, possibly facilitated by long-term virus persistence within carrier stallions.
Two major groups are evident from the phylogenetic analysis of G L (Fig. 1) . Group I contains mainly viruses from North America, while group II includes mostly viruses from Europe. The presence of the ' European ' viruses NL1 and GB2 in group I and of two ' American ' viruses USA8 and USA18 in group II is explained by movement of stallions between Europe and America. It is very likely that these animals were carriers of the virus at the time of their shipment. For example, NL1 originated from a Dutch Warmblood horse, which was shipped to the West Coast of the USA in the middle of the 1980s. Isolate USA8 was detected in the USA, but the horse originated from Poland and spent 1 year in Sweden before being shipped to America in 1986. Similarly, the ' New Zealand ' virus, which groups with American viruses, and the ' Norwegian ' viruses N1 and N2 were also isolated from horses imported from the USA. It is more difficult to reconcile the categorization of USA2, an American isolate from 1963, in group II. The source of the isolate, an American Saddlebred, is very unlikely to have been in Europe, especially since international transportation of horses was still in its infancy at that time. Indirect transmission of this virus from another horse imported from Europe could be an explanation.
Both groups are divided into subgroups. Most group I viruses belong to subgroup I.A which contains Canadian and USA isolates, together with the New Zealand isolate (NZ1) and the NL1 and GB2 isolates of apparent European origin. Subgroup I.B is composed of four viruses from Canada. In group II, three separate subgroups (II.A, II.B and II.C) are identifiable and represented by the A1 (Austria, 1968) , F3 (France, 1986) and I1 (Italy, 1990\91) isolates. Subgroup II.A comprises viruses from Austria, France, Germany, Italy, Poland and the UK. One virus isolate of apparent American origin (USA8 ; USA, 1987) also belongs to this subgroup. Subgroup II.B contains isolates from France, Germany, Italy and Norway, while subgroup II.C includes viruses from Italy and Poland. These groupings were shown to be statistically significant by bootstrap analysis. There are a number of relatively distinctive isolates, for which it was difficult to predict their branch nodes precisely. Strains CH1 and S1 fall between the two main groups. In group I, several strains were found (USA1, PL1, ARVAC, USA17, USA3, N1, N2) which are distantly related to each other, but distinct from the viruses in subgroups I.A GJF Fig. 2 . Phylogenetic tree of 28 isolates of EAV. The tree was constructed from a 369 nt fragment of the replicase gene by the Fitch-Margoliash method. The lengths of branches reflect phylogenetic distances. The numbers represent the percentage of times particular branch patterns were predicted after bootstrap resampling of the data. and I.B ; the very low bootstrap value (27) does not justify their inclusion into a separate subgroup. In group II, the USA2 strain could not be assigned to any of the subgroups.
It must be emphasized that the groupings are phylogenetically based and result from predictions of likely patterns of evolutionary diversification. They cannot be deduced from a simple comparison of genetic similarities. For example, PL2 in group II.C has more nucleotide matches to CDN1 in group I.B than to F2 in group II.A. The phylogenetic trees must therefore be interpreted with caution and in the knowledge that some relationships may change when new sequence data become available. Nevertheless, the fact that group I viruses are almost all from America and group II are almost all from Europe strongly supports these predictions. Sugita et al. (1994) studied the evolution of the M gene of seven EAV isolates, including only three European isolates, namely CH1 (Switzerland, 1964), A1 (Austria, 1968) and PL2 (Poland, 1976\77) . The results of the current study reveal that the A1 strain represents a large group of virus isolates from various countries of Europe whereas, so far, CH1 forms a separate outgroup by itself.
Previously, the largest phylogenetic comparison was carried out by and Hedges et al. (1996) . They compared the G L -and G S -coding sequences of four laboratory strains, the modified live virus vaccine strain (ARVAC ; Ft Dodge Labs) and 18 field isolates from North America and Europe. Four genetically distinct groups were identified, i.e. two North American groups (NA1 and NA2) and two European groups (E1 and E2). However, NA2 and E1 each comprised only a single isolate (USA2 and CH1, respectively), whilst E2 comprised only three European isolates. Their North American group NA1 and European group E2 correspond to the groups I and II.A of the present study. They assigned the CH1 strain to a monophyletic subgroup of E1, while we found that this strain could not be assigned to either of our major groups. The unique phylogenetic position of the CH1 virus is not only based on sequence data of the G L region ; data for the other parts of the genome, such as the M, N and replicase genes are also very different (Chirnside et al., 1994 ; . The peculiar genetic character of USA2 was noted by , and is confirmed in the present study. In addition to CH1, we found another distinctive and ungroupable virus in isolate S1. This was isolated from a Swedish Standardbred Trotter stallion, born in 1978 in Sweden. The horse has competed at race tracks in Sweden, but its current location is unknown and there are no data available on the possible source of infection. It remains to be seen whether CH1 and S1 will remain as outgroup viruses or whether more closely related EAV isolates await discovery ; the CH1 strain was one of the earliest isolates of EAV made in Europe.
It is interesting that isolate USA17 appeared identical to ARVAC, since it was isolated from an aborted foetus from a mare that had been vaccinated 5 days earlier with the live attenuated ARVAC vaccine. Therefore, it can not be excluded that the vaccine virus played a role in the abortion.
Replicase gene sequences are not expected to be subject to immune selection and are likely to be more conserved than those encoding structural proteins such as G L . This was found to be the case in the present study. However, the predicted relationship between viruses was similar in both trees, and there was no suggestion that the two genes studied had undergone separate evolution in different viruses, before being brought together by virus recombination. This is contrary to the suggestion by Chirnside et al. (1994) who studied the M and N gene sequences of ten EAV isolates, mostly included in the current study, and suggested that RNA recombination between EAV isolates may have occurred. Our phylogenetic tree revealed two statistically significant groupings which corresponded to group I and subgroup II.A of the G L tree (Fig.  2) . While viruses belonging to subgroup II.B of the G L tree were branched separately in the replicase tree, this determination was not clear-cut (bootstrap value 60). As with the G L tree, isolates I1, CH1 and S1 formed separate branches.
Antigenic considerations
The position and character of the deduced amino acid sequence differences within the G L protein suggest that it has a highly conserved overall structure. However, several potential antigenic determinants were revealed, all within the variable regions V " and V $ proposed by . The deduced amino acid sequences of the most variable region (V " ) of the amplified G L fragments are illustrated in Fig. 3 . This shows clustering of substitutions at positions 61-62, 67-90, 100-106 and 118-121. Computer analysis based on the Jameson-Wolf algorithm indicated that some of the amino acid alterations in the G L protein would result in significant changes in antigenicity. Antigenic profiles for a selection of viruses are provided in Fig. 4 . These reveal that the most marked alterations occur in the V " region, reflecting many non-conservative amino acid substitutions. In the case of V $ , only strain USA2 has a different antigenic structure compared to the rest of the viruses which were analysed.
Most of the antigenic determinants coincided with the regions where neutralizing epitopes have been defined (Chirnside et al., 1995 ; Glaser et al., 1995 ; Balasuriya et al., a, 1997 . By using a panel of 17 MAbs raised against strain USA2 and a neutralization-resistant variant, Balasuriya et al. (1997) identified four distinct neutralization sites. These included amino acids 49 (site A), 61 (site B), 67-90 (site C) and 99-106 (site D). With the exception of site A, the others were all located in the V " variable region. Site D was found to include several overlapping linear epitopes which appear to interact with amino acids in the other three sites to form conformationally dependent epitopes. The authors found that amino acid substitutions within any of these four sites can alter the neutralization phenotype of individual strains of EAV (Balasuriya et al., 1997) . Considering the importance of G L in virus neutralization, this protein might logically be targeted to a peptide or a subunit vaccine. However, it will be desirable to establish whether neutralization-critical epitopes are consistently expressed on all field isolates of EAV. Although our study did not include site A, it did reveal a remarkable variability in the amino acid residues that make up sites B, C and D among the viruses analysed. This suggests that field isolates with differing neutralizing phenotypes may be a reality (Fig. 4) .
In summary, viruses obtained from a wide geographic distribution and isolated over a 40 year period, were used to provide the most comprehensive assessment to date of the extent of genetic diversity amongst EAV isolates. By comparing the sequences of 67 isolates of EAV, two phylo- Fig. 4 . Comparison of antigenic profiles for a part of the G L protein of selected EAV isolates as predicted by the method described by Jameson & Wolf (1988) . Peaks extending upward indicate potential antigenic sites. Variable regions are shaded in light grey . Amino acids involved in neutralizing epitopes are shaded in dark grey. genetic groups of virus were identified. Group I contained mainly viruses from North America, while group II represented mainly viruses from Europe. Several subgroups are present within each group, and two other isolates formed separate groups of their own. The results of this study confirm the importance of the variable region of the G L gene for phylogenetic grouping of EAV isolates. The latter provides an estimate of the genetic diversity among strains of the virus, a rapid means for identification of newly emerging variants and a useful tool for tracing routes by which EAV is spread. In addition, the data highlight the need for a comprehensive assessment of the antigenic variability of the G L protein prior to its use as a subunit vaccine against EVA.
